Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages era-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages era

Published:2024-07 Issue: Volume:144 Page:107042
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Vergori Alessandra^ORCID,Cozzi Lepri Alessandro,Chiuchiarelli Marta,Mazzotta Valentina,Metafuni Elisabetta^ORCID,Matusali Giulia,Siciliano Valentina,Paulicelli Jessica,Alma Eleonora,Siniscalchi Agostina,Sica Simona,Abruzzese Elisabetta^ORCID,Fantoni Massimo,Antinori Andrea,Cingolani Antonella

Funder

Administration for Community Living

Ministero della Salute

Publisher

Elsevier BV

Reference10 articles.

1. Clinical characteristics and outcome of immunocompromised patients with COVID-19 caused by the Omicron variant: a prospective observational study;Malahe;Clin Infect Dis,2022

2. Efficacy of COVID-19 vaccines in patients taking immunosuppressants;Shen;Ann Rheum Dis,2022

3. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies;Cao;Nature,2022

4. Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies;Bruel;Nat Med,2022

5. Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies;Bruel;Cell Rep Med,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP